Global Statins Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Statins Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body.
Statins report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Statins market is projected to reach US$ 16430 million in 2034, increasing from US$ 14430 million in 2022, with the CAGR of 1.8% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Statins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AstraZeneca
Pfizer
GlaxoSmithKline
Novartis International
Merck
Biocon
Concord Biotech
Aurobindo Pharma
Segment by Type
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
Hospitals
Clinics
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Statins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Statins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Statins industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Statins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Statins introduction, etc. Statins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Statins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Statins report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Statins market is projected to reach US$ 16430 million in 2034, increasing from US$ 14430 million in 2022, with the CAGR of 1.8% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Statins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AstraZeneca
Pfizer
GlaxoSmithKline
Novartis International
Merck
Biocon
Concord Biotech
Aurobindo Pharma
Segment by Type
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
Segment by Application
Hospitals
Clinics
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Statins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Statins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Statins industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Statins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Statins introduction, etc. Statins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Statins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.